Generate a tailored SOP for Dr. Lev Becker. Improve your application with a focused, well-structured draft.
Lev Becker is an Associate Professor at the University of Chicago, focusing on macrophage dysregulation and its implications in chronic sterile inflammatory diseases, cancer, atherosclerosis, and obesity/type 2 diabetes. His research seeks to elucidate the specific changes in macrophage pathways that contribute to disease pathogenesis and pathogen clearance. Leveraging a multi-disease approach, Becker's lab employs proteomic, bioinformatic, immunologic, and functional methodologies to develop a comprehensive understanding of macrophage biology. Their long-term goal is to translate these insights into therapeutics for various human diseases, including cancers and metabolic disorders. Notably, they are developing new anti-inflammatory therapies targeting macrophages, aiming to enhance pathogen clearance while treating conditions such as atherosclerosis and type 2 diabetes.
University of Chicago • Chicago, IL
Conducting research on macrophage dysregulation and its role in chronic inflammatory diseases.
A series of therapies developed to target dysregulated macrophages.
Department of Philosophy